, ,,(a),in respect of an application relating to an orphan medicinal product to which point 6 of Part 2 of Annex 1 to the 2001 Directive applies,£32,135 , ,,(b),which is a mutual recognition procedure incoming application,£67,468 , ,,(c),which is a European reference product application,£67,468, ,,(d),which is a decentralised procedure application where the United Kingdom is a concerned Member State,£96,797 , ,,(e),which is a decentralised procedure application where the United Kingdom is a reference Member State,£139,235 , ,,(f),in any other case,£100,252, , ,,(a),which is a mutual recognition procedure incoming application,£18,732 , ,,(b),which is a European reference product application,£18,732 , ,,(c),which is a decentralised procedure application where the United Kingdom is a concerned Member State,£26,762, ,,(d),which is a decentralised procedure application where the United Kingdom is a reference Member State,£40,780 , ,,(e),in any other case,£27,716, , ,,(a),which is a mutual recognition procedure incoming application,£6,864 , ,,(b),which is a European reference product application,£6,864 , ,,(c),which is a decentralised procedure application where the United Kingdom is a concerned Member State,£9,812, ,,(d),which is a decentralised procedure application where the United Kingdom is a reference Member State,£17,920 , ,,(e),in any other case,£10,162, , ,,(a),which is a decentralised procedure application where the United Kingdom is a concerned Member State,£2,771 , ,,(b),which is a decentralised procedure application where the United Kingdom is a reference Member State,£9,275, ,,(c),in any other case,£2,771, , ,,(a),in respect of a simple parallel import licence,£1,937, ,,(b),in respect of a standard parallel import licence,£7,201, ,,(c),in respect of a complex parallel import licence,£19,650, £478, 1. An application in respect of a product which is both prepared solely from repeat stocks and is of a repeat formulation,£558,£791, 2. An application in respect of a product which is either—,£874,£1,096, ,(a),prepared solely from repeat stocks; or,,, (b),is of a repeat formulation,,, 3. Any other application,£1,176,£1,418, Phase I trial,£2,255, Phase II or Phase III trial where the medicinal product being tested is unknown to the licensing authority,£4,244, Phase II or Phase III trial where the product being tested is known to the licensing authority,£3,448, Phase IV trial,£265, , ,(a),in respect of a medicinal product containing a single active ingredient,£5,237, ,(b),in any other case,£7,857, , ,(a),in respect of a medicinal product containing 3 or fewer active ingredients,£2,619, ,(b),in any other case,£3,928, , ,(a),in respect of a medicinal product containing 3 or fewer active ingredients,£873, ,(b),in any other case,£1,310, , ,(a),in respect of a medicinal product containing 3 or fewer active ingredients,£583, ,(b),in any other case,£873, £478, , ,,(a),Type IB Application where—,, ,,,(i),the UK is a concerned Member State,£300 , ,,,(ii),the UK is the reference Member State or the licensing authority is the reference authority for work sharing,£594 , ,,(b),Type II Application where—,, ,,,(i),the UK is a concerned Member State,£794 , ,,,(ii),the UK is the reference Member State or the licensing authority is the reference authority for work sharing,£962, ,,(c),Type II Complex Variation Application where—,, ,,,(i),the UK is a concerned Member State,£8,981 , ,,,(ii),the UK is the reference Member State or the licensing authority is the reference authority for work sharing,£15,571 , ,,(d),Extended Type II Complex Variation Application where—,, ,,,(i),the UK is a concerned Member State,£27,716 , ,,,(ii),the UK is the reference Member State or the licensing authority is the reference authority for work sharing ,£38,744, 2. Applications for a Group,, ,,(a),Minor Variation (Type IB) Group Application where—,, ,,,(i),the UK is a concerned Member State,£672 , ,,,(ii),the UK is the reference Member State or the licensing authority is the reference authority for work sharing,£1,324 , ,,(b),Major Variation (Type II ) Group Application where—,, ,,,(i),the UK is a concerned Member State,£1,786 , ,,,(ii),the UK is the reference Member State or the licensing authority is the reference authority for work sharing,£2,158, ,,(c),Major Variation (Type II ) Complex Group Application where—,, ,,,(i),the UK is a concerned Member State,£9,738 , ,,,(ii),the UK is the reference Member State or the licensing authority is the reference authority for work sharing,£16,465 , ,,(d),Major Variation (Type II ) Extended Complex Group Application where—,, ,,,(i),the UK is a concerned Member State,£28,401 , ,,,(ii),the UK is the reference Member State or the licensing authority is the reference authority for work sharing,£39,693, 1. National Type 1B Application,£300, 2. National Type II Application,£794, 3. National Type II Complex Variation Application,£8,981, 4. National Type II Extended Complex Variation Application,£27,716, 5. National Type IB Minor Variation Group Application,£672, 6. National Type II Major Variation Group Application,£1,786, 7. National Type II Major Variation Complex Group Application,£9,738, 8. National Type II Major Variation Extended Complex Group Application,£28,401, Application falling within the category described in—,, ,,(a),paragraph 15(a),£12,961, ,,(b),paragraph 15(b),£8,822, 1. New Active Substance,£23,025, 2. Parallel Import,£300, 3. Others,, ,(a),Any product (not being a derivative of a new active substance) in respect of which a marketing authorization has been granted in consequence of a complex application submitted on or after 1st April 1989,£9,481, ,(b),Prescription Only Medicine,, ,,(i),Standard Fee,£2,371, ,,(ii),Reduced Rate Fee,£1,183, ,,(iii),Lower Fee,£300, ,(c),Pharmacy,£300, ,(d),General Sale List,£300, ,(e),Herbal remedy,£75, ,(f),Traditional herbal registrations,£75, ,(g),National homoeopathic product,£75, ,(h),Homoeopathic or anthroposophic product which is the subject of a licence of right,£75, 1 to 20,£126, 21 to 100,£505, 101 to 1,000,£2,020, 1,001 to 5,000,£10,100, 5,001 to 20,000,£25,250, 20,001 to 50,000,£50,500, 50,001 to 100,000,£101,000, 100,001 or more,£151,500, 1,An application in respect of a product which is both prepared solely from repeat stocks and is of a repeat formulation.,£172,£425, 2,An application in respect of a product which is either—,£517,£761, ,(a),prepared solely from repeat stocks; or,,, ,(b),is of a repeat formulation.,,, 3,A mutual recognition procedure incoming application.,£542,£690, 4,A mutual recognition outgoing application (regulatory assistance).,£310,£405, 5,A decentralised procedure application where the UK is a concerned Member State.,£465,£608, 6,A decentralised procedure application where the UK is the reference Member State.,£930,£1,217, 7,Any other application.,£854,£1,118,